✦ LIBER ✦

Cimzia's setback paves way for other TNF inhibitors in Crohn's disease

✍ Scribed by Sheridan, Cormac

Book ID: 109903238
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 115 KB
Volume: 25
Category: Article
ISSN: 1087-0156
DOI: 10.1038/nbt0507-487

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P211 - Efficacy of adalimumab in paediat

P211 - Efficacy of adalimumab in paediatric Crohn's disease patients naive to other anti-TNF treatments

✍ J. Martín de Carpi; N. Pociello; S. Pinillos; K. Chávez; P. Vilar; V. Varea 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 48 KB

P020 EFFICACY OF A THIRD ANTI-TNF MONOCL

P020 EFFICACY OF A THIRD ANTI-TNF MONOCLONAL ANTIBODY IN CROHN'S DISEASE AFTER FAILURE OF TWO OTHER ANTI-TNF

✍ M. Allez; N. Mozziconacci; S. Vermeire; D. Laharie; E. Louis; M. Bigard; X. Hebu 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 76 KB

W1244 Efficacy of a Third Anti-TNF Monoc

W1244 Efficacy of a Third Anti-TNF Monoclonal Antibody in Crohn's Disease After Failure of Two Other Anti-TNF

✍ Mozziconacci, Nicolas; Vermeire, Severine; Laharie, David; Louis, Edouard; Bigar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Long-term efficacy of adalimumab in Paed

Long-term efficacy of adalimumab in Paediatric Crohn's disease patients naïve to other anti-TNF therapies

✍ J. Martín-de-Carpi; N. Pociello; V. Varea 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 177 KB

Anti-TNF therapies have eliminated the n

Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease

✍ Dr. Richard J. Grand 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Fecal calprotectin, lactoferrin, and end

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

✍ Taina Sipponen; Erkki Savilahti; Päivi Kärkkäinen; Kaija-Leena Kolho; Hannu Nuut 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Background: Fecal calprotectin and lactoferrin are promising noninvasive biomarkers for intestinal inflammation. In Crohn's disease (CD), during anti-TNF-alpha (TNF-␣) treatment, the clinical significance of these markers has, however, been insufficiently explored. Methods: Among CD patients receiv